FLONASE ALLERGY RELIEF is a Nasal Spray, Metered in the Human Otc Drug category. It is labeled and distributed by Glaxosmithkline Consumer Healthcare Holdings (us) Llc. The primary component is Fluticasone Propionate.
| Product ID | 0135-0576_1f0c6c8a-8452-45ae-8ed6-517e855d70b9 |
| NDC | 0135-0576 |
| Product Type | Human Otc Drug |
| Proprietary Name | FLONASE ALLERGY RELIEF |
| Generic Name | Fluticasone Propionate |
| Dosage Form | Spray, Metered |
| Route of Administration | NASAL |
| Marketing Start Date | 2014-12-04 |
| Marketing Category | NDA / NDA |
| Application Number | NDA205434 |
| Labeler Name | GlaxoSmithKline Consumer Healthcare Holdings (US) LLC |
| Substance Name | FLUTICASONE PROPIONATE |
| Active Ingredient Strength | 50 ug/1 |
| NDC Exclude Flag | N |
| Listing Certified Through | 2022-12-31 |
| Marketing Start Date | 2016-06-30 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | NDA |
| Application Number | NDA205434 |
| Product Type | HUMAN OTC DRUG |
| Billing Unit | ML |
| Marketing Start Date | 2014-12-04 |
| Marketing Category | NDA |
| Application Number | NDA205434 |
| Product Type | HUMAN OTC DRUG |
| Billing Unit | ML |
| Marketing Start Date | 2015-01-07 |
| Marketing Category | NDA |
| Application Number | NDA205434 |
| Product Type | HUMAN OTC DRUG |
| Billing Unit | ML |
| Marketing Start Date | 2017-03-20 |
| Marketing Category | NDA |
| Application Number | NDA205434 |
| Product Type | HUMAN OTC DRUG |
| Marketing Start Date | 2016-02-29 |
| Marketing Category | NDA |
| Application Number | NDA205434 |
| Product Type | HUMAN OTC DRUG |
| Marketing Start Date | 2016-06-30 |
| Marketing Category | NDA |
| Application Number | NDA205434 |
| Product Type | HUMAN OTC DRUG |
| Billing Unit | ML |
| Marketing Start Date | 2014-12-04 |
| Marketing Category | NDA |
| Application Number | NDA205434 |
| Product Type | HUMAN OTC DRUG |
| Billing Unit | ML |
| Marketing Start Date | 2017-03-20 |
| Marketing Category | NDA |
| Application Number | NDA205434 |
| Product Type | HUMAN OTC DRUG |
| Billing Unit | ML |
| Marketing Start Date | 2016-11-17 |
| Marketing Category | NDA |
| Application Number | NDA205434 |
| Product Type | HUMAN OTC DRUG |
| Billing Unit | ML |
| Marketing Start Date | 2019-01-22 |
| Ingredient | Strength |
|---|---|
| FLUTICASONE PROPIONATE | 50 ug/1 |
| SPL SET ID: | b6134ba0-b70a-4eac-9a82-cef64b242c1d |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 70518-1223 | FLONASE ALLERGY RELIEF | FLONASE ALLERGY RELIEF |
| 50090-1978 | FLONASE ALLERGY RELIEF | FLONASE ALLERGY RELIEF |
| 0113-7117 | basic care allergy relief nasal | Fluticasone propionate |
| 0135-0582 | CHILDRENS FLONASE | fluticasone propionate |
| 0135-0576 | FLONASE | fluticasone propionate |
| 0173-0600 | FLOVENT | fluticasone propionate |
| 0173-0601 | FLOVENT | fluticasone propionate |
| 0173-0602 | FLOVENT | fluticasone propionate |
| 0173-0718 | FLOVENT | fluticasone propionate |
| 0054-3270 | Fluticasone Propionate | Fluticasone Propionate |
| 0168-0332 | FLUTICASONE PROPIONATE | fluticasone propionate |
| 0168-0333 | Fluticasone Propionate | fluticasone propionate |
| 0168-0434 | FLUTICASONE PROPIONATE | fluticasone propionate |
| 0113-0028 | Good Sense 24 hour allergy nasal | Fluticasone propionate |
| 0113-0285 | Good Sense 24 hour allergy nasal | Fluticasone Propionate |
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
![]() FLONASE 97701366 not registered Live/Pending |
GlaxoSmithKline Consumer Healthcare (UK) IP Limited 2022-12-02 |
![]() FLONASE 97121742 not registered Live/Pending |
Glaxo Group Limited 2021-11-12 |
![]() FLONASE 86746149 4959825 Live/Registered |
Glaxo Group Limited 2015-09-02 |
![]() FLONASE 85958560 4809013 Live/Registered |
Glaxo Group Limited 2013-06-13 |
![]() FLONASE 74389190 1870977 Live/Registered |
GLAXO GROUP LIMITED 1993-05-11 |
![]() FLONASE 74109574 not registered Dead/Abandoned |
GLAXO GROUP LIMITED 1990-10-26 |